...Ministry of Health, Labor and Welfare (MHLW) approved an expanded label for Remitch nalfurafine from Toray...
...will promote Remitch at medical institutions, and Torii will be responsible for distributing the drug. Toray...
...supply Remitch to Torii, which already markets the compound in Japan (see BioCentury, March 30). Toray Industries Inc....

...will promote Remitch at medical institutions and Torii will be responsible for distributing the drug. Toray...
...rights to the product in North America. Mitsubishi Tanabe Pharma Corp . (Tokyo:4508), Osaka, Japan Toray Industries Inc....

...C$5 million ($3.9 million) Shares: 9 million Price: C$0.55 Shares after offering: 188.8 million Investor: Toray...

...C$18.2 million ($16.7 million) Shares: 45.1 million Price: C$0.29 Shares outstanding prior: 134.5 million Investors: Toray...
...of C$13.2 million ($12.1 million) through the sale of 45.1 million shares at $0.29 to Toray...
...other existing investors and a second tranche of up to C$5 million ($4.6 million) to Toray...

...EMA said Toray withdrew an MAA for Winfuran nalfurafine to treat severe uremic pruritus in patients...
...opioid receptor agonist has Orphan Drug designation in the EU to treat hemodialysis-related uremic pruritus. Toray...
...rights in Europe (see BioCentury, Oct. 31, 2011). Mitsubishi Tanabe Pharma Corp. (Tokyo:4508), Osaka, Japan Toray Industries Inc....

...On Dec. 19, 2013, EMA's CHMP recommended against approval of an MAA from Toray for Winfuran...
...opioid receptor agonist has Orphan Drug designation in the EU to treat hemodialysis-related uremic pruritus. Toray...
...an oral formulation of the product in Japan as Remitch for the indication. In 2011, Toray...

...C$5.6 million ($5.5 million) Shares: 18.7 million Price: C$0.30 Shares after offering: 119.9 million Investor: Toray...

...C$5.6 million ($5.5 million) Shares: 18.7 million Price: C$0.30 Shares outstanding prior: 101.3 million Investor: Toray...

...C$5 million ($4.9 million) Shares: 16.7 million Price: C$0.30 Shares outstanding prior: 101.3 million Investor: Toray...

...according to Good. Toray Industries Inc. markets nalfurafine as Remitch in Japan to treat hemodialysis-related uremic pruritus. Toray...
...& Co. KGaA (Xetra:FRE), Bad Homburg, Germany Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Toray Industries Inc....